“…Taking into consideration that thioflavin-T (ThT) is the most widely used (in vitro) indicator of Aβ aggregation displaying fluorescence enhancement and a characteristic red shift when binding to Aβ aggregates, the decoration of nanoliposomes with benzothiazoles (BTH), the moiety that is responsible for the affinity of ThT towards Aβ aggregates [24,25,26], may potentially be an improved method for Aβ targeting. In fact, benzothiazoles bearing only the 2-benzothiazolyl-moiety [27,28,29,30], or more complicated 2-benzothiazolyl-derivatives [31,32,33,34,35,36], have been prepared and tested for their affinity towards amyloids, however none of the previous molecules were ever tested after immobilization on nanoliposomes. Additionally, it should be pointed out that the bulky and ionic nature of ThT is a negative parameter for its permeation across the blood–brain barrier (BBB), explaining why no benefits were obtained from this compound in vivo [37,38,39,40].…”